ReviewCancers2022

New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors.

Katarzyna Szklener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.